Skip to main content
PMC home page
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1996 Mar;34(3):516–519. doi: 10.1128/jcm.34.3.516-519.1996

Isolation of enterohemorrhagic Escherichia coli O157 strains from patients with hemolytic-uremic syndrome by using immunomagnetic separation, DNA-based methods, and direct culture.

H Karch 1, C Janetzki-Mittmann 1, S Aleksic 1, M Datz 1
PMCID: PMC228837  PMID: 8904405

Abstract

We examined 30 children with classical hemolytic-uremic syndrome (HUS) for the presence of enterohemorrhagic Escherichia coli (EHEC) strains in stool samples and determined the specific immune response to O157 lipopolysaccharide in acute-phase serum samples from these patients. EHEC O157 strains were isolated from stool samples of 18 (60%) of the patients, and non-O157 EHEC strains were isolated from 5 (17%) of the patients. For O157 strain isolation from stools, we introduced a selective enrichment step using O157-specific antibodies attached to paramagnetic particles (immunomagnetic separation [IMS] method). This procedure allowed the detection of O157 strains at 10(2) CFU/g of stool in the presence of 10(7) coliform background flora organisms. By using IMS followed by plating on sorbitol MacConkey (SMAC) agar and cefixime-tellurite SMAC (CT-SMAC) agar, O157 strains were detected in 18 samples, whereas colony hybridization detected a subset of 12 positive samples and direct culture on CT-SMAC or SMAC agar detected only 7. Three of the 18 O157-positive stools were negative by cytotoxicity assay performed with stool filtrates and by direct PCR with DNA extracted from stools. The IMS technique allowed the isolation of O157 strains from 18 of 20 patients with serological evidence for O157 infection. Apart from the increase in sensitivity in O157 detection compared with that of direct culture, the IMS technique also has the advantage of being less labor-intensive and less time-consuming than the molecular methods. IMS can therefore be considered an efficient method for wide-spread use in the detection of O157 strains in clinical microbiology laboratories. However, because a significant number of HUS cases were attributable to non-O157 EHEC serogroups, the use of additional methods besides IMS in the bacteriological diagnosis of HUS is necessary.

Full Text

The Full Text of this article is available as a PDF (164.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aleksić S., Karch H., Bockemühl J. A biotyping scheme for Shiga-like (Vero) toxin-producing Escherichia coli O157 and a list of serological cross-reactions between O157 and other gram-negative bacteria. Zentralbl Bakteriol. 1992 Jan;276(2):221–230. doi: 10.1016/s0934-8840(11)80009-5. [DOI] [PubMed] [Google Scholar]
  2. Belongia E. A., Osterholm M. T., Soler J. T., Ammend D. A., Braun J. E., MacDonald K. L. Transmission of Escherichia coli O157:H7 infection in Minnesota child day-care facilities. JAMA. 1993 Feb 17;269(7):883–888. [PubMed] [Google Scholar]
  3. Bitzan M., Moebius E., Ludwig K., Müller-Wiefel D. E., Heesemann J., Karch H. High incidence of serum antibodies to Escherichia coli O157 lipopolysaccharide in children with hemolytic-uremic syndrome. J Pediatr. 1991 Sep;119(3):380–385. doi: 10.1016/s0022-3476(05)82049-9. [DOI] [PubMed] [Google Scholar]
  4. Caprioli A., Luzzi I., Rosmini F., Resti C., Edefonti A., Perfumo F., Farina C., Goglio A., Gianviti A., Rizzoni G. Community-wide outbreak of hemolytic-uremic syndrome associated with non-O157 verocytotoxin-producing Escherichia coli. J Infect Dis. 1994 Jan;169(1):208–211. doi: 10.1093/infdis/169.1.208. [DOI] [PubMed] [Google Scholar]
  5. Carter A. O., Borczyk A. A., Carlson J. A., Harvey B., Hockin J. C., Karmali M. A., Krishnan C., Korn D. A., Lior H. A severe outbreak of Escherichia coli O157:H7--associated hemorrhagic colitis in a nursing home. N Engl J Med. 1987 Dec 10;317(24):1496–1500. doi: 10.1056/NEJM198712103172403. [DOI] [PubMed] [Google Scholar]
  6. Chapman P. A., Siddons C. A., Zadik P. M., Jewes L. An improved selective medium for the isolation of Escherichia coli O157. J Med Microbiol. 1991 Aug;35(2):107–110. doi: 10.1099/00222615-35-2-107. [DOI] [PubMed] [Google Scholar]
  7. Chapman P. A., Wright D. J., Siddons C. A. A comparison of immunomagnetic separation and direct culture for the isolation of verocytotoxin-producing Escherichia coli O157 from bovine faeces. J Med Microbiol. 1994 Jun;40(6):424–427. doi: 10.1099/00222615-40-6-424. [DOI] [PubMed] [Google Scholar]
  8. Chart H., Smith H. R., Scotland S. M., Rowe B., Milford D. V., Taylor C. M. Serological identification of Escherichia coli O157:H7 infection in haemolytic uraemic syndrome. Lancet. 1991 Jan 19;337(8734):138–140. doi: 10.1016/0140-6736(91)90801-u. [DOI] [PubMed] [Google Scholar]
  9. Griffin P. M., Tauxe R. V. The epidemiology of infections caused by Escherichia coli O157:H7, other enterohemorrhagic E. coli, and the associated hemolytic uremic syndrome. Epidemiol Rev. 1991;13:60–98. doi: 10.1093/oxfordjournals.epirev.a036079. [DOI] [PubMed] [Google Scholar]
  10. Karch H., Rüssmann H., Schmidt H., Schwarzkopf A., Heesemann J. Long-term shedding and clonal turnover of enterohemorrhagic Escherichia coli O157 in diarrheal diseases. J Clin Microbiol. 1995 Jun;33(6):1602–1605. doi: 10.1128/jcm.33.6.1602-1605.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Karmali M. A., Arbus G. S., Ish-Shalom N., Fleming P. C., Malkin D., Petric M., Cheung R., Louie S., Humphreys G. R., Strachan M. A family outbreak of hemolytic-uremic syndrome associated with verotoxin-producing Escherichia coli serotype O157:H7. Pediatr Nephrol. 1988 Oct;2(4):409–414. doi: 10.1007/BF00853433. [DOI] [PubMed] [Google Scholar]
  12. Karmali M. A., Petric M., Lim C., Fleming P. C., Arbus G. S., Lior H. The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli. J Infect Dis. 1985 May;151(5):775–782. doi: 10.1093/infdis/151.5.775. [DOI] [PubMed] [Google Scholar]
  13. Kleanthous H., Fry N. K., Smith H. R., Gross R. J., Rowe B. The use of sorbitol-MacConkey agar in conjunction with a specific antiserum for the detection of Vero cytotoxin-producing strains of Escherichia coli O 157. Epidemiol Infect. 1988 Oct;101(2):327–335. doi: 10.1017/s0950268800054261. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Ramotar K., Waldhart B., Church D., Szumski R., Louie T. J. Direct detection of verotoxin-producing Escherichia coli in stool samples by PCR. J Clin Microbiol. 1995 Mar;33(3):519–524. doi: 10.1128/jcm.33.3.519-524.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Rüssmann H., Schmidt H., Heesemann J., Caprioli A., Karch H. Variants of Shiga-like toxin II constitute a major toxin component in Escherichia coli O157 strains from patients with haemolytic uraemic syndrome. J Med Microbiol. 1994 May;40(5):338–343. doi: 10.1099/00222615-40-5-338. [DOI] [PubMed] [Google Scholar]
  16. Scotland S. M., Rowe B., Smith H. R., Willshaw G. A., Gross R. J. Vero cytotoxin-producing strains of Escherichia coli from children with haemolytic uraemic syndrome and their detection by specific DNA probes. J Med Microbiol. 1988 Apr;25(4):237–243. doi: 10.1099/00222615-25-4-237. [DOI] [PubMed] [Google Scholar]
  17. Tarr P. I., Neill M. A., Clausen C. R., Watkins S. L., Christie D. L., Hickman R. O. Escherichia coli O157:H7 and the hemolytic uremic syndrome: importance of early cultures in establishing the etiology. J Infect Dis. 1990 Aug;162(2):553–556. doi: 10.1093/infdis/162.2.553. [DOI] [PubMed] [Google Scholar]
  18. Wright D. J., Chapman P. A., Siddons C. A. Immunomagnetic separation as a sensitive method for isolating Escherichia coli O157 from food samples. Epidemiol Infect. 1994 Aug;113(1):31–39. doi: 10.1017/s0950268800051438. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Zadik P. M., Chapman P. A., Siddons C. A. Use of tellurite for the selection of verocytotoxigenic Escherichia coli O157. J Med Microbiol. 1993 Aug;39(2):155–158. doi: 10.1099/00222615-39-2-155. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES